Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review

Paul Brennan (Lead / Corresponding author), Kathleen Clare, Jacob George, John F. Dillon

Research output: Contribution to journalReview articlepeer-review

41 Downloads (Pure)

Abstract

There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of this as a putative diagnostic and prognostic biomarker in NAFLD. Given the increased economic and health burden associated with the NAFLD epidemic, improved methods of population-based, minimally-invasive methods and biomarkers are clearly highly sought and necessary. In this opinion review we review the proposed role of uric acid in the pathogenesis of NAFLD and its potential utilisation in the diagnosis and monitoring of the disease process.
Original languageEnglish
Pages (from-to)1683-1690
Number of pages8
JournalWorld Journal of Gastroenterology
Volume26
Issue number15
Early online date21 Apr 2020
DOIs
Publication statusPublished - 21 Apr 2020

Keywords

  • Fatty liver index
  • Non-alcoholic fatty liver disease
  • Non-alcoholic steatohepatitis
  • Non-invasive fibrosis markers
  • Urate
  • Uric acid

Fingerprint Dive into the research topics of 'Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review'. Together they form a unique fingerprint.

Cite this